Cortera Neurotechnologies, Inc. logo

Cortera Neurotechnologies, Inc.

Cortera Neurotechnologies, Inc. is a medical devices company developing neurotechnology as a therapy to treat neuropsychiatric disorders such as major depressive disorder, and post traumatic stress disorder.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://corteraneuro.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
2150 Shattuck Ave.,CA 94704
Berkeley
United States
Email
Contact Number
+1 510 883 0270

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/cortera-neurotechnologies-inc-” connections=”true” suffix=””]

Cortera is developing an implantable neural interface capable of recording and stimulating the human central nervous system and the system will be used to treat neuropsychiatric disorders.

Cortera has received grants and awards from U.S. governments Defense Advanced Research Projects Agency (DARPA) (as part of the Obama BRAIN initiative), the NIH, UC Berkeley, The University of Melbourne and the State of Victoria in Australia.